Swiss National Bank Nkarta, Inc. Transaction History

Swiss National Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$5.14 - $14.35 $362,370 - $1.01 Million	70,500 New	70,500 $422,000
Q2 2022 Aug 09, 2022	SELL	$7.77 - $19.44 $197,358 - $493,776	-25,400 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$12.79 - $26.88 $86,972 - $182,784	6,800 Added 36.56%	25,400 $390,000
Q1 2021 May 07, 2021	BUY	$31.33 - $59.61 $119,054 - $226,518	3,800 Added 25.68%	18,600 $612,000
Q4 2020 Feb 05, 2021	BUY	$27.03 - $75.62 $400,044 - $1.12 Million	14,800 New	14,800 $910,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $127M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.